FOR IMMEDIATE RELEASE

NOTICE OF PALADIN LAB'S FIRST QUARTER RESULTS CONFERENCE CALL

Montreal, Canada, April 28, 2005 - Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, will release its first quarter financial results on Thursday, May 5, 2005 prior to market opening. Following the release, Paladin will hold a conference call at 10:00 a.m. (EST) hosted by Jonathan Ross Goodman, President and CEO of Paladin Labs. Paladin cordially invites all interested parties to participate in this call.

CONFERENCE CALL DETAILS:

DATE:	Thursday, May 5, 2005
TIME:	10:00 a.m. EST
DIAL IN NUMBER:	1-888-789-0150 or 416-695-6120
TAPED REPLAY:	1-888-509-0082 OR 416-695-5275 Available from Thursday, May 5th at noon until Thursday, May 12th at midnight.

The call will also be audio-cast live and archived for 90 days at www.paladinlabs.com and www.financialdisclosure.ca.

About Paladin Labs Inc.
Paladin Labs Inc., headquartered in Montreal, Quebec, is a leading specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. With this strategy, a focused national sales team and proven marketing expertise, Paladin has evolved into one of Canada’s leading specialty pharmaceutical companies. Paladin’s shares trade on the Toronto Stock Exchange under the symbol PLB. For more information about Paladin, please visit the Paladin web site at www.paladinlabs.com

For further information please contact:

Paladin Labs Inc.
Samira Sakhia, Chief Financial Officer
Tel: 514-340-5067
e-mail: info@paladin-labs.com
Web Site: www.paladinlabs.com